Literature DB >> 34992979

Recurrent Hypothalamic Dysfunction in Seropositive Neuromyelitis Optica.

Mary Clare McKenna1, Nuala McNicholas1, Conor Fearon1, David Bradley1.   

Abstract

Entities:  

Year:  2021        PMID: 34992979      PMCID: PMC8723957          DOI: 10.1212/CPJ.0000000000001012

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


× No keyword cloud information.
  6 in total

1.  Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica.

Authors:  R Iorio; C F Lucchinetti; V A Lennon; C Costanzi; S Hinson; B G Weinshenker; S J Pittock
Journal:  Neurology       Date:  2011-10-12       Impact factor: 9.910

2.  Hypocretinergic dysfunction in neuromyelitis optica with coma-like episodes.

Authors:  B Carlander; T Vincent; A Le Floch; N Pageot; W Camu; Y Dauvilliers
Journal:  BMJ Case Rep       Date:  2009-02-02

3.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Authors:  Sean J Pittock; Brian G Weinshenker; Claudia F Lucchinetti; Dean M Wingerchuk; John R Corboy; Vanda A Lennon
Journal:  Arch Neurol       Date:  2006-07

4.  Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.

Authors:  Sean J Pittock; Achim Berthele; Kazuo Fujihara; Ho Jin Kim; Michael Levy; Jacqueline Palace; Ichiro Nakashima; Murat Terzi; Natalia Totolyan; Shanthi Viswanathan; Kai-Chen Wang; Amy Pace; Kenji P Fujita; Róisín Armstrong; Dean M Wingerchuk
Journal:  N Engl J Med       Date:  2019-05-03       Impact factor: 91.245

5.  Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Authors:  Toshiyuki Takahashi; Kazuo Fujihara; Ichiro Nakashima; Tatsuro Misu; Isabelle Miyazawa; Masashi Nakamura; Shohei Watanabe; Yusei Shiga; Chihiro Kanaoka; Juichi Fujimori; Shigeru Sato; Yasuto Itoyama
Journal:  Brain       Date:  2007-04-19       Impact factor: 13.501

6.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.